Sonoma Pharmaceuticals (SNOA) Current Assets (2011 - 2025)

Sonoma Pharmaceuticals' Current Assets history runs 15 years deep, the most recent figure standing at $12.1 million for Q4 2025.

• In Q4 2025, Current Assets fell 1.9% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at $12.1 million (down 1.9% YoY), while the FY2025 annual figure was $12.6 million, up 0.8% from the prior year.
• Current Assets was $12.1 million for Q4 2025 at Sonoma Pharmaceuticals, down from $12.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $18.0 million in Q3 2021 to a low of $11.2 million in Q4 2022.
• Historically, Current Assets has averaged $13.3 million across 5 years, with a median of $12.5 million in 2023.
• Biggest YoY gain for Current Assets was 26.55% in 2022; the steepest drop was 36.54% in 2022.
• A 5-year view of Current Assets shows it stood at $17.7 million in 2021, then sank by 36.54% to $11.2 million in 2022, then grew by 11.31% to $12.5 million in 2023, then decreased by 0.98% to $12.4 million in 2024, then retreated by 1.9% to $12.1 million in 2025.
• The last three Current Assets figures came in at $12.1 million (Q4 2025), $12.5 million (Q3 2025), and $13.1 million (Q2 2025), per Business Quant data.